Core Viewpoint - The announcement details the change of the sponsor representative for Jianer Kang Medical Technology Co., Ltd. due to the work relocation of the previous representative, ensuring the continuity of supervision during the IPO process [1]. Group 1: Change of Sponsor Representative - Jianer Kang Medical Technology Co., Ltd. received a notice from CITIC Securities regarding the change of its sponsor representative for the ongoing IPO supervision [1]. - The original representatives were Zhu Beihang and Lü Yan, with the supervision period lasting until December 31, 2026 [1]. - Zhu Beihang will be replaced by Hao Yongchao to maintain orderly supervision [1]. Group 2: Acknowledgment and New Representative's Background - The company expresses gratitude for Zhu Beihang's contributions during the supervision period [1]. - Hao Yongchao holds a master's degree and is a qualified Chinese CPA, currently serving as a senior vice president at CITIC Securities [3]. - Hao Yongchao has participated in various IPO projects, demonstrating a strong background in the field [3].
健尔康: 健尔康医疗科技股份有限公司关于变更保荐代表人的公告